Project Grant F31CA284500
Award Date
12/1/24
Completion Date
6/30/26
Dollars Obligated
$124K
Federal Agency
National Cancer Institute
Federal Grant Program
93.398
Assistance Type
Project Grant
Place of Performance
ROXBURY CROSSING, MA 02120, USA
Similar Awards
The President and Fellows of Harvard College, doing business as Harvard Medical School, was awarded a $4,597,818 project grant from the National Cancer Institute within the Department of Health and Human Services. The grant is funded under the 21st Century Cures Act - Beau Biden Cancer Moonshot program (CFDA 93.353), which supports cancer research initiatives. Under this award, Harvard Medical School will develop an integrative visualization framework for spatial single-cell cancer datasets...
This $1,186,517 Project Grant was awarded by the Defense Health Agency on August 1, 2023 to Harvard College President & Fellows Of Harvard T.H. Chan School Of Public Health under the Military Medical Research and Development (CFDA 12.420) program. The goal of the 3-year project is to REVEAL AND TARGET LIPIDOMIC VULNERABILITIES TO TREAT METASTATIC MELANOMA. Harvard T.H. Chan School of Public Health will conduct research to investigate new ways to treat this deadly form of skin cancer. No...
This federal Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) provides $163,967 to President and Fellows of Harvard College (Harvard Medical School) to conduct research on defining the functional and spatial properties of tumor-specific, tumor-infiltrating CD8 T cells. The key objectives are to: Generate patient-derived xenograft (PDX) mouse models of melanoma to test the required diversity of T cell receptors (TCRs) from tumor-infiltrating T...
This $1,014,000 project grant from the Defense Health Agency will fund research into targeted therapeutic opportunities for ovarian clear cell, small cell, and endometrioid carcinomas at President And Fellows of Harvard College from May 1, 2023 to April 30, 2027. The grant falls under the Military Medical Research and Development program, which supports basic, applied, and advanced biomedical research to transform military and public health care through innovative medical solutions. Through this...
This federal Project Grant award for $1,352,000.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research to transform healthcare for military service members, veterans, and the public. The award, with a performance period from August 1, 2025 to July 31, 2029, is focused on targeted therapy development through spatial molecular profiling for rare pediatric and adult brain tumors using limited...
The U.S. Department of Defense's Defense Health Agency awarded a $539,904 Project Grant titled "GENOMICALLY INFORMED MORPHOLOGICAL STROMAL SIGNATURES TO PREDICT LETHAL PROSTATE CANCER" to the President and Fellows of Harvard College's Harvard T.H. Chan School of Public Health. The grant, which runs from June 15, 2025 to June 14, 2028, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically,...
The Defense Health Agency awarded a $716,069 Project Grant to President And Fellows Of Harvard College, doing business as Harvard Medical School, to conduct research from September 1, 2023 through August 31, 2025. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform health care for service members and the public through innovative research and investigate medical solutions for the...
This federal Project Grant award, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research on the regulation of steroid hormone signaling and lipid metabolism by the tuberous sclerosis complex. The $254,233 award was granted to President and Fellows of Harvard College, specifically the Harvard Medical School, for the performance period of April 1, 2025 to March 31, 2027. This research project aims to advance the...
This $676,147 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports a research initiative led by Harvard University to develop data-driven biomarker-informed decision analytics to improve the efficacy and reduce the toxicity of immune checkpoint blockade therapy for melanoma patients. The 3-year project aims to leverage advanced analytics and biomarker data to optimize the use of this cutting-edge cancer...
This federal Project Grant award of $676,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research at Harvard Medical School to develop HUWE1 as a therapeutic target for treating mesothelioma. The award period runs from July 1, 2025 to June 30, 2027. The research aims to advance medical solutions for the battlefield and transform healthcare for military service members, veterans, and the public through innovative and impactful...